長期投資家のためのIR情報
バリュートレンド

【7575】日本ライフライン
医療機器販売。輸入商社。特に心臓分野。

売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2027.03 2026/07/30 Q1予 63,200 → 0.0% 0.0% 10,700 → 0.0% 0.0% 10,800 → 0.0% 0.0% 8,000 → 0.0% 0.0%
2027.03 2026/05/07 当初予 63,200 - - - 10,700 - - - 10,800 - - - 8,000 - - -
2026.03 2026/05/07 実 59,187 ↓ -0.2% -0.2% 12,606 ↓ -2.3% -2.3% 12,588 ↓ -3.2% -3.2% 9,350 → 0.0% 0.0%
2026.03 2026/01/30 Q3予 59,300 → 0.0% 0.0% 12,900 → 0.0% 0.0% 13,000 → 0.0% 0.0% 9,350 → 0.0% 0.0%
2026.03 2025/10/29 Q2予 59,300 → 0.0% 0.0% 12,900 → 0.0% 0.0% 13,000 → 0.0% 0.0% 9,350 → 0.0% 0.0%
2026.03 2025/07/31 Q1予 59,300 → 0.0% 0.0% 12,900 → 0.0% 0.0% 13,000 → 0.0% 0.0% 9,350 → 0.0% 0.0%
2026.03 2025/05/07 当初予 59,300 - - - 12,900 - - - 13,000 - - - 9,350 - - -
2025.03 2025/05/07 実 56,610 ↓ -0.3% +4.8% 12,326 ↓ -2.2% +10.1% 12,335 ↓ -2.1% +12.1% 9,317 ↑ +1.3% +16.5%
2025.03 2025/01/31 修正予 56,800 ↑ +5.2% +5.2% 12,600 ↑ +12.5% +12.5% 12,600 ↑ +14.5% +14.5% 9,200 ↑ +15.0% +15.0%
2025.03 2024/10/31 Q2予 54,000 → 0.0% 0.0% 11,200 → 0.0% 0.0% 11,000 → 0.0% 0.0% 8,000 → 0.0% 0.0%
2025.03 2024/07/31 Q1予 54,000 → 0.0% 0.0% 11,200 → 0.0% 0.0% 11,000 → 0.0% 0.0% 8,000 → 0.0% 0.0%
2025.03 2024/05/01 当初予 54,000 - - - 11,200 - - - 11,000 - - - 8,000 - - -
2024.03 2024/05/01 実 51,384 ↑ +1.4% +5.3% 10,892 ↓ -0.5% +11.6% 10,581 ↓ -2.4% +11.0% 7,515 ↓ -4.9% +9.6%
2024.03 2024/02/02 Q3予 50,680 → 0.0% +3.8% 10,945 → 0.0% +12.1% 10,844 → 0.0% +13.8% 7,902 → 0.0% +15.3%
2024.03 2023/11/06 修正予 50,680 ↑ +3.8% +3.8% 10,945 ↑ +12.1% +12.1% 10,844 ↑ +13.8% +13.8% 7,902 ↑ +15.3% +15.3%
2024.03 2023/08/02 Q1予 48,807 → 0.0% 0.0% 9,763 → 0.0% 0.0% 9,531 → 0.0% 0.0% 6,854 → 0.0% 0.0%
2024.03 2023/05/10 当初予 48,807 - - - 9,763 - - - 9,531 - - - 6,854 - - -
2023.03 2023/05/10 実 51,750 ↑ +1.3% +0.4% 10,837 ↑ +5.8% +8.3% 10,905 ↑ +6.7% +9.0% 6,891 ↑ +12.5% -5.3%
2023.03 2023/02/01 修正予 51,090 ↓ -0.8% -0.8% 10,241 ↑ +2.3% +2.3% 10,224 ↑ +2.2% +2.2% 6,128 ↓ -15.8% -15.8%
2023.03 2022/11/02 Q2予 51,527 → 0.0% 0.0% 10,011 → 0.0% 0.0% 10,003 → 0.0% 0.0% 7,274 → 0.0% 0.0%
2023.03 2022/07/29 Q1予 51,527 → 0.0% 0.0% 10,011 → 0.0% 0.0% 10,003 → 0.0% 0.0% 7,274 → 0.0% 0.0%
2023.03 2022/05/11 当初予 51,527 - - - 10,011 - - - 10,003 - - - 7,274 - - -
2022.03 2022/05/11 実 51,469 ↓ -2.9% -2.9% 9,973 ↓ -6.1% -6.1% 10,005 ↓ -6.3% -6.3% 7,484 ↓ -1.1% -1.1%
2022.03 2021/08/04 Q1予 52,979 → 0.0% 0.0% 10,625 → 0.0% 0.0% 10,682 → 0.0% 0.0% 7,567 → 0.0% 0.0%
2022.03 2021/05/07 当初予 52,979 - - - 10,625 - - - 10,682 - - - 7,567 - - -
2021.03 2021/05/07 実 51,286 ↓ -1.0% -3.6% 10,367 ↓ -0.7% +3.7% 10,519 ↑ +3.4% +6.4% 2,000 ↓ -12.5% -70.7%
2021.03 2021/01/29 Q3予 51,787 ↓ -2.7% -2.7% 10,438 ↑ +4.4% +4.4% 10,170 ↑ +2.9% +2.9% 2,286 ↓ -66.5% -66.5%
2021.03 2020/10/28 Q2予 53,226 → 0.0% 0.0% 10,001 → 0.0% 0.0% 9,882 → 0.0% 0.0% 6,827 → 0.0% 0.0%
2021.03 2020/08/05 当初予 53,226 - - - 10,001 - - - 9,882 - - - 6,827 - - -
2020.03 2020/05/12 実 51,761 ↓ -1.3% -4.3% 10,434 ↓ -1.2% -0.3% 10,425 ↓ -3.3% -6.6% 7,748 ↑ +1.0% +0.0%
2020.03 2020/01/31 Q3予 52,450 → 0.0% -3.0% 10,562 → 0.0% +0.9% 10,784 → 0.0% -3.4% 7,675 → 0.0% -0.9%
2020.03 2019/11/05 修正予 52,450 ↓ -3.0% -3.0% 10,562 ↑ +0.9% +0.9% 10,784 ↓ -3.4% -3.4% 7,675 ↓ -0.9% -0.9%
2020.03 2019/07/31 Q1予 54,059 → 0.0% 0.0% 10,465 → 0.0% 0.0% 11,167 → 0.0% 0.0% 7,747 → 0.0% 0.0%
2020.03 2019/04/26 当初予 54,059 - - - 10,465 - - - 11,167 - - - 7,747 - - -
2019.03 2019/04/26 実 45,525 ↓ -2.6% -7.9% 10,526 ↑ +1.4% -6.0% 10,808 ↑ +0.6% -5.9% 7,723 ↑ +2.6% -1.3%
2019.03 2019/01/31 Q3予 46,762 → 0.0% -5.4% 10,383 → 0.0% -7.3% 10,745 → 0.0% -6.4% 7,530 → 0.0% -3.8%
2019.03 2018/11/02 修正予 46,762 ↓ -5.4% -5.4% 10,383 ↓ -7.3% -7.3% 10,745 ↓ -6.4% -6.4% 7,530 ↓ -3.8% -3.8%
2019.03 2018/07/27 Q1予 49,411 → 0.0% 0.0% 11,202 → 0.0% 0.0% 11,482 → 0.0% 0.0% 7,825 → 0.0% 0.0%
2019.03 2018/05/02 当初予 49,411 - - - 11,202 - - - 11,482 - - - 7,825 - - -
2018.03 2018/05/02 実 42,298 ↓ -0.4% +1.1% 10,671 ↑ +0.1% +12.7% 10,730 ↓ -1.6% +11.7% 7,478 ↓ -0.0% +11.9%
2018.03 2018/01/31 Q3予 42,466 ↑ +1.5% +1.5% 10,664 ↑ +12.6% +12.6% 10,908 ↑ +13.6% +13.6% 7,480 ↑ +11.9% +11.9%
2018.03 2017/11/02 Q2予 41,828 → 0.0% 0.0% 9,472 → 0.0% 0.0% 9,604 → 0.0% 0.0% 6,684 → 0.0% 0.0%
2018.03 2017/07/28 Q1予 41,828 → 0.0% 0.0% 9,472 → 0.0% 0.0% 9,604 → 0.0% 0.0% 6,684 → 0.0% 0.0%
2018.03 2017/04/28 当初予 41,828 - - - 9,472 - - - 9,604 - - - 6,684 - - -
2017.03 2017/04/28 実 37,181 ↓ -2.1% +7.2% 7,685 ↑ +11.9% +64.0% 8,010 ↑ +15.5% +65.8% 5,350 ↑ +16.2% +72.5%
2017.03 2017/01/31 Q3予 37,991 → 0.0% +9.5% 6,866 → 0.0% +46.5% 6,935 → 0.0% +43.5% 4,604 → 0.0% +48.4%
2017.03 2016/07/29 修正予 37,991 ↑ +9.5% +9.5% 6,866 ↑ +46.5% +46.5% 6,935 ↑ +43.5% +43.5% 4,604 ↑ +48.4% +48.4%
2017.03 2016/05/02 当初予 34,699 - - - 4,686 - - - 4,832 - - - 3,102 - - -
2016.03 2016/05/02 実 30,540 → 0.0% +3.2% 3,700 → 0.0% +32.9% 3,574 ↓ -0.2% +26.3% 2,804 ↑ +2.0% +29.2%
2016.03 2016/04/15 修正予 30,540 ↑ +3.2% +3.2% 3,700 ↑ +32.9% +32.9% 3,580 ↑ +26.5% +26.5% 2,749 ↑ +26.6% +26.6%
2016.03 2016/01/29 Q3予 29,584 → 0.0% 0.0% 2,785 → 0.0% 0.0% 2,829 → 0.0% 0.0% 2,171 → 0.0% 0.0%
2016.03 2015/11/02 Q2予 29,584 → 0.0% 0.0% 2,785 → 0.0% 0.0% 2,829 → 0.0% 0.0% 2,171 → 0.0% 0.0%
2016.03 2015/08/03 Q1予 29,584 → 0.0% 0.0% 2,785 - - - 2,829 → 0.0% 0.0% 2,171 → 0.0% 0.0%
2016.03 2015/04/30 当初予 29,584 - - - - - - - 2,829 - - - 2,171 - - -
2015.03 2015/04/30 実 - - - - - - - - - - - - - - - -
2015.03 2015/01/30 Q3予 25,749 → 0.0% +0.8% 1,751 → 0.0% +62.7% 1,800 → 0.0% +66.5% 903 → 0.0% +83.9%
2015.03 2014/11/05 Q2予 25,749 → 0.0% +0.8% 1,751 ↑ +62.7% +62.7% 1,800 → 0.0% +66.5% 903 → 0.0% +83.9%
2015.03 2014/10/24 修正予 25,749 ↑ +0.8% +0.8% - - - - 1,800 ↑ +66.5% +66.5% 903 ↑ +83.9% +83.9%
2015.03 2014/07/31 Q1予 25,539 → 0.0% 0.0% 1,076 → 0.0% 0.0% 1,081 → 0.0% 0.0% 491 → 0.0% 0.0%
2015.03 2014/05/02 当初予 25,539 - - - 1,076 - - - 1,081 - - - 491 - - -
2014.03 2014/05/02 実 24,371 ↑ +0.4% +0.4% 1,219 ↑ +2.9% +2.9% 1,336 ↓ -0.2% -0.2% -202 ↑ +31.5% +31.5%
2014.03 2014/04/09 当初予 24,264 - - - 1,185 - - - 1,339 - - - -295 - - -
シェア ツイート
ページトップへ戻る